UK High Court upholds Alcon glaucoma patent
27-04-2021
Roche enters $200m hep B treatment collaboration
31-10-2019
Amgen and Roche target Samsung’s Bioepis in patent suit
01-05-2019
Grand Warszawski / Shutterstock.com
The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
English High Court, Takeda, Roche, patent validity, Crohn’s disease, ulcerative colitis, Entyvio
